Alliancebernstein L.P. Revolution Medicines, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 194,078 shares of RVMD stock, worth $7.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

194,078

Previous 234,929 17.39%

Holding current value

$7.32 Million

Previous $10.3 Million 33.22%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$35.36 - $44.42 $1.44 Million - $1.81 Million	-40,851 Reduced 17.39%	194,078 $6.86 Million
Q4 2024 Feb 12, 2025	SELL	$42.97 - $60.6 $684,598 - $965,479	-15,932 Reduced 6.35%	234,929 $10.3 Million
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $2.54 Million - $3.3 Million	-68,757 Reduced 21.51%	250,861 $11.4 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $112,904 - $152,387	-3,746 Reduced 1.16%	319,618 $12.4 Million
Q1 2024 May 14, 2024	BUY	$26.56 - $33.55 $82,840 - $104,642	3,119 Added 0.97%	323,364 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $1.18 Million - $2.19 Million	64,202 Added 25.07%	320,245 $9.18 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $1.83 Million - $2.54 Million	-72,595 Reduced 22.09%	256,043 $7.09 Million
Q2 2023 Aug 15, 2023	SELL	$20.28 - $27.0 $969,627 - $1.29 Million	-47,812 Reduced 12.7%	328,638 $8.79 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $3.32 Million - $4.82 Million	160,050 Added 73.96%	376,450 $8.15 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $669,400 - $966,616	-37,862 Reduced 14.89%	216,400 $5.15 Million
Q3 2022 Nov 15, 2022	BUY	$17.46 - $26.0 $994,608 - $1.48 Million	56,965 Added 28.87%	254,262 $5.01 Million
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $412,514 - $770,840	-28,371 Reduced 12.57%	197,297 $3.85 Million
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $2.08 Million - $3.17 Million	120,086 Added 113.74%	225,668 $5.76 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $474,386 - $656,543	19,482 Added 22.63%	105,582 $2.66 Million
Q3 2021 Nov 10, 2021	BUY	$23.95 - $33.41 $479,000 - $668,199	20,000 Added 30.26%	86,100 $2.37 Million
Q2 2021 Jul 30, 2021	BUY	$29.0 - $47.44 $258,100 - $422,216	8,900 Added 15.56%	66,100 $2.1 Million
Q1 2021 May 06, 2021	BUY	$37.21 - $54.43 $33,489 - $48,987	900 Added 1.6%	57,200 $2.62 Million
Q4 2020 Feb 08, 2021	BUY	$30.19 - $45.49 $12,076 - $18,196	400 Added 0.72%	56,300 $2.23 Million
Q3 2020 Nov 12, 2020	BUY	$22.61 - $34.8 $763,607 - $1.18 Million	33,773 Added 152.63%	55,900 $1.95 Million
Q2 2020 Aug 13, 2020	BUY	$19.65 - $39.34 $434,795 - $870,476	22,127 New	22,127 $699,000

Others Institutions Holding RVMD

# of Institutions

303

Shares Held

189M

Call Options Held

186K

Put Options Held

672K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.31B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Revolution Medicines, Inc. Transaction History